Ann: ePAT validation tests successful-MNQ.AX, page-14

Meh ... Hope I'm wrong about this but let's put this into perspective - it's a 17 patient in the trial.

I assume the regulatory bodies will not need massive numbers like they do for new drugs but my hunch is they will need a bigger study than this. Can one of the RAPpers comment on the numbers in the trials for their app pls

Look It's good start for mnq but they need bigger numbers and hopefully this gets some more funding on these results

Hope it re rates to 5c but I doubt it on this Ann alone